Hemorrhagic Posterior Reversible Encephalopathy Syndrome in a Patient With Larynx Carcinoma

Ogul H., Kiziloglu A., Ogul Y.

Ear, Nose and Throat Journal, 2023 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Basım Tarihi: 2023
  • Doi Numarası: 10.1177/01455613221150121
  • Dergi Adı: Ear, Nose and Throat Journal
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE, Directory of Open Access Journals
  • Anahtar Kelimeler: haemorrhagic posterior reversible encephalopathy syndrome, ondensatron, magnetic resonance imaging, susceptibility weighted imaging, SPECTRUM
  • Atatürk Üniversitesi Adresli: Evet

Özet

© The Author(s) 2023.Significance Statement Posterior reversible encephalopathy syndrome (PRES) is characterized by variable neurological findings such as headache, deterioration in mental condition, loss of consciousness and visual loss. The disease results with impairment of the cerebral blood flow autoregulation. Ondansetron, serotonin (5HT-3) receptor antagonist, may cause the haemorrhagic PRES.